JNJ-38877618

• Description:

  JNJ-38877618 (OMO-1) is a novel potent, highly selective, orally bioavailable c-Met tyrosine kinase inhibitor.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  374.355

• Molecular Formula:

  C20H12F2N6

• Notes:

  Research use only, not for human use.

• Receptor:

  C-Met/HGFR

• CAS Number:

  943540-74-7